Medical device and MedTech insights, news, tips and more

Class I Recall Issued by FDA for Abbott’s HeartMate 3 Heart Pump

May 23, 2018


The FDA issued a Class I recall for Abbott’s HeartMate 3 left ventricular assist device due to possible twisting of the outflow graft that could result in a persistent low-flow alarm, which normally signals potential safety risks including low blood flow or clotting that could lead to serious injury or death.

The regulatory agency recommends that patients experiencing a persistent low-flow alarm should contact the physician managing their HeartMate 3 device immediately. The company, which began contacting physicians earlier this month, said it was aware of 32 reports of outflow graft twisting in the device and three deaths possibly associated with such an event.

The device assists in delivering blood from the heart to the rest of the body, the agency said, and is used for short-term support of patients who are at risk of death from end-stage left ventricular heart failure. The HeartMate 3 system includes a blood pump that is implanted in the space around the heart along with an outflow graft that connects the pump to the aorta. The recall covers all 4,878 units distributed nationwide since September 2017.

Read More at the Source: FDA issues Class I recall for Abbott’s HeartMate 3 heart pump | FierceBiotech
Read the FDA Recall Here: Safety Alerts for Human Medical Products

By Joseph Keenan


A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & development, quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.